Literature DB >> 29675582

Multifunctional Opioid Ligands.

Jessica P Anand1, Deanna Montgomery2.   

Abstract

The opioid receptor system plays a major role in the regulation of mood, reward, and pain. The opioid receptors therefore make attractive targets for the treatment of many different conditions, including pain, depression, and addiction. However, stimulation or blockade of any one opioid receptor type often leads to on-target adverse effects that limit the clinical utility of a selective opioid agonist or antagonist. Literature precedent suggests that the opioid receptors do not act in isolation and that interactions among the opioid receptors and between the opioid receptors and other proteins may produce clinically useful targets. Multifunctional ligands have the potential to elicit desired outcomes with reduced adverse effects by allowing for the activation of specific receptor conformations and/or signaling pathways promoted as a result of receptor oligomerization or crosstalk. In this chapter, we describe several classes of multifunctional ligands that interact with at least one opioid receptor. These ligands have been designed for biochemical exploration and the treatment of a wide variety of conditions, including multiple kinds of pain, depression, anxiety, addiction, and gastrointestinal disorders. The structures, pharmacological utility, and therapeutic drawbacks of these classes of ligands are discussed.

Entities:  

Keywords:  Anxiety; Bivalent; Depression; GPCR; Mixed efficacy; Mood; Multifunctional; Opioid; Pain; Reward

Mesh:

Substances:

Year:  2018        PMID: 29675582     DOI: 10.1007/164_2018_104

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  13 in total

1.  MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.

Authors:  Diana V Atigari; Rajendra Uprety; Gavril W Pasternak; Susruta Majumdar; Bronwyn M Kivell
Journal:  Neuropharmacology       Date:  2019-02-13       Impact factor: 5.250

2.  Novel Dimethyltyrosine-Tetrahydroisoquinoline Peptidomimetics with Aromatic Tetrahydroisoquinoline Substitutions Show in Vitro Kappa and Mu Opioid Receptor Agonism.

Authors:  Deanna Montgomery; Jessica P Anand; Nicholas W Griggs; Thomas J Fernandez; Joshua G Hartman; Ashley A Sánchez-Santiago; Irina D Pogozheva; John R Traynor; Henry I Mosberg
Journal:  ACS Chem Neurosci       Date:  2019-07-01       Impact factor: 4.418

3.  Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviour.

Authors:  Ariana C Brice-Tutt; Lisa L Wilson; Shainnel O Eans; Heather M Stacy; Chloe A Simons; Grant G Simpson; Jeremy S Coleman; Michael J Ferracane; Jane V Aldrich; Jay P McLaughlin
Journal:  Br J Pharmacol       Date:  2020-07-16       Impact factor: 8.739

4.  Opioid receptors signaling network.

Authors:  Lathika Gopalakrishnan; Oishi Chatterjee; Namitha Ravishankar; Sneha Suresh; Rajesh Raju; Anita Mahadevan; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2021-11-01       Impact factor: 5.908

5.  Structure-Activity Relationships of 7-Substituted Dimethyltyrosine-Tetrahydroisoquinoline Opioid Peptidomimetics.

Authors:  Deanna Montgomery; Jessica P Anand; Mason A Baber; Jack J Twarozynski; Joshua G Hartman; Lennon J Delong; John R Traynor; Henry I Mosberg
Journal:  Molecules       Date:  2019-11-26       Impact factor: 4.411

6.  Phenylalanine Stereoisomers of CJ-15,208 and [d-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles.

Authors:  Ariana C Brice-Tutt; Sanjeewa N Senadheera; Michelle L Ganno; Shainnel O Eans; Tanvir Khaliq; Thomas F Murray; Jay P McLaughlin; Jane V Aldrich
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

7.  The Dose-Dependent Effects of Multifunctional Enkephalin Analogs on the Protein Composition of Rat Spleen Lymphocytes, Cortex, and Hippocampus; Comparison with Changes Induced by Morphine.

Authors:  Hana Ujcikova; Lenka Roubalova; Yeon Sun Lee; Jirina Slaninova; Jana Brejchova; Petr Svoboda
Journal:  Biomedicines       Date:  2022-08-14

8.  Multifunctional Enkephalin Analogs with a New Biological Profile: MOR/DOR Agonism and KOR Antagonism.

Authors:  Yeon Sun Lee; Michael Remesic; Cyf Ramos-Colon; Zhijun Wu; Justin LaVigne; Gabriella Molnar; Dagmara Tymecka; Aleksandra Misicka; John M Streicher; Victor J Hruby; Frank Porreca
Journal:  Biomedicines       Date:  2021-05-31

9.  Discovery of Novel µ-Opioid Receptor Inverse Agonist from a Combinatorial Library of Tetrapeptides through Structure-Based Virtual Screening.

Authors:  Giulio Poli; Marilisa Pia Dimmito; Adriano Mollica; Gokhan Zengin; Sandor Benyhe; Ferenc Zador; Azzurra Stefanucci
Journal:  Molecules       Date:  2019-10-27       Impact factor: 4.411

10.  Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking.

Authors:  Maria Dumitrascuta; Marcel Bermudez; Olga Trovato; Jolien De Neve; Steven Ballet; Gerhard Wolber; Mariana Spetea
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.